Found: 18
Select item for more details and to access through your institution.
Complications of intracerebroventricular chemotherapy via subgaleal reservoir in primary central nervous system lymphoma: A single‐institution experience on 1247 installations in 94 consecutive patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 176, doi. 10.1002/hon.2833
- By:
- Publication type:
- Article
Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 196, doi. 10.1002/hon.2830
- By:
- Publication type:
- Article
Trimethoprim‐sulfamethoxazole as Pneumocystis jiroveci pneumonia prevention in patients undergoing methotrexate therapy for hematological malignancies: A review of the literature.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 170, doi. 10.1002/hon.2823
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. i, doi. 10.1002/hon.2866
- By:
- Publication type:
- Article
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
- By:
- Publication type:
- Article
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 231, doi. 10.1002/hon.2834
- By:
- Publication type:
- Article
Obinutuzumab-related adverse events: A systematic review and meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 205, doi. 10.1002/hon.2827
- By:
- Publication type:
- Article
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 267, doi. 10.1002/hon.2826
- By:
- Publication type:
- Article
Direct‐acting antivirals in hepatitis C virus‐positive mantle cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 263, doi. 10.1002/hon.2825
- By:
- Publication type:
- Article
Hsa_circ_0002483 regulates miR-758-3p/MYC axis to promote acute myeloid leukemia progression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Acute myeloid leukemia arising from polycythemia vera underwent reversion to chronic phase of myeloproliferative neoplasm status post chemotherapy: Biclonal myeloid neoplasms with genomic evidence of a common early hematopoietic progenitor.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 254, doi. 10.1002/hon.2824
- By:
- Publication type:
- Article
Successful salvage of primary progressive Hodgkin lymphoma with the combination of post‐transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 258, doi. 10.1002/hon.2801
- By:
- Publication type:
- Article
Therapeutic targets in childhood B‐acute lymphoblastic leukemia: what about HER2/neu?
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 270, doi. 10.1002/hon.2799
- By:
- Publication type:
- Article
How to select older patients with acute myeloid leukemia fit for intensive treatment?
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 151, doi. 10.1002/hon.2798
- By:
- Publication type:
- Article
Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 162, doi. 10.1002/hon.2793
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 149, doi. 10.1002/hon.2746
- Publication type:
- Article